Sidney Kimmel Cancer Center at Thomas Jefferson University: Prostatic Neoplasms trials

The registry lists 16 Prostatic Neoplasms studies with Sidney Kimmel Cancer Center at Thomas Jefferson University as lead sponsor. 0 are open to participants now and 6 have results posted.

Phase 1 7Phase 2 3Phase 3 1No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSACompletedNCT02989623Not applicableResults posted
• Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate CancerCompletedNCT01848067Phase 1/2Results posted
• Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate CancerTerminatedNCT01313559Phase 2Results posted
• Digoxin for Recurrent Prostate CancerCompletedNCT01162135Phase 2Results posted
• Contrast Enhanced Transrectal Ultrasonography (TRUS) to Assess Prostatic Vascularity After Radiotherapy (XRT)TerminatedNCT00635167Not applicableResults posted
• Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate CancerCompletedNCT00328614Phase 1Results posted
• Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)CompletedNCT03807492
• Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate CancerWithdrawnNCT03477864Phase 1
• Electronic Patient Reported Outcomes in Measuring Health-Related Quality of Life in Patients With Stage I-IV Prostate Cancer Undergoing TreatmentTerminatedNCT03197948
• Genetic Evaluation of Men (GEM)TerminatedNCT03076242
• Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad)CompletedNCT03076203Phase 1
• Ultrasound-Based Imaging Using the Aixplorer System in Diagnosing Prostate Cancer in Patients Undergoing BiopsyCompletedNCT03013413Not applicable
• Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing SurgeryCompletedNCT02603965Phase 1
• Cabazitaxel With Radiation and Hormone Therapy for Prostate CancerCompletedNCT01420250Phase 1
• Robotic Seed Implantation for Prostate Cancer BrachytherapyTerminatedNCT01341288Phase 1
• Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate CancerCompletedNCT00398281Phase 3